Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Alerts clinicians to papillary muscle dysfunction across severity spectra; leaves open need for prospective validation of management strategies.
ALTHOUGH the role of the papillary muscles in mitral-valve closure has been appreciated for over a century1 , 2 the clinical importance of disease of these structures has emerged only within the past decade. It is now recognized that there is a broad clinical spectrum of papillary-muscle malfunction, ranging from a transient murmur in the asymptomatic patient with ischemic papillary-muscle dysfunction3 , 4 to florid mitral regurgitation and acute, fulminant pulmonary edema in the patient with papillary-muscle rupture.5 6 7 Ischemic malfunction of the papillary muscles was thought to cause mitral regurgitation as early as 1935,8 and this mechanism was further emphasized by Burch and Phillips . . .
No takes yet. Share an insight, caveat, or question.
Busk et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: